Metraipolis › archive › dc_ccc62531bfe5
Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42222162
- DOI
- 10.3389/fphar.2026.1831031
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:46:26.757Z
- SHA-256 of the archived text
e6a780012e326648ebb3afd0ace140e125334e7f9b22905b43f3936a154c58fa- Stable URL of this page
https://metraipolis.com/documento/dc_ccc62531bfe5
How to cite
Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162 — Europe PMC (en), https://europepmc.org/article/MED/42222162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccc62531bfe5 (Metraipolis archive dc_ccc62531bfe5, sha256 e6a780012e326648ebb3afd0ace140e125334e7f9b22905b43f3936a154c58fa)
BibTeX
@misc{dcccc62531bfe5,
title = {Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42222162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccc62531bfe5; sha256 e6a780012e326648ebb3afd0ace140e125334e7f9b22905b43f3936a154c58fa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222162. Agents can read the archived copy with the MCP tool read_document.